logo

For the Inventor, By the Inventor

Lawrence, KS, United States of America

Joseph A Fix

This inventor holds 17 USPTO granted patents and 6 published patent applications and 1 EPO patent, primarily in Pharmaceutical Formulations. Top assignees: Merck + Co., Inc., Ezra Pharma LLC, Rubicon Research Private Limited. Active years: 1984-2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Joseph A Fix. Retrieved from https://idiyas.com/inventor/joseph-a-fix

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 17 

% Patents Active = 82.4


Average Co-Inventor Count = 2.5

ph-index = 12

Forward Citations = 253(Granted Patents)


Company Filing History:

goldMedal13 out of 4,770 
 
Merck + Co., Inc.
 patents
silverMedal3 out of 3 
 
Ezra Pharma LLC
 patents
bronzeMedal3 out of 12 
 
Rubicon Research Private Limited
 patents
4. 1 out of 1 
 
White Sands Pharma LLC
 patent
where one patent can have more than one assignee

Years Active: 1984-2022

Loading Chart...
Loading Chart...
Areas of Expertise:
Extended Release
Pharmaceutical Formulations
Drug Absorption
Controlled Impurity Levels
Acylcarnitines
Choline Esters
Gastrointestinal Drug Delivery
Adjuvants
Lysine Esters
17 patents (USPTO):Explore Patents
1. 11419868 - Low dose product and method for treating diarrhea (2022-08-23),
2. 10010529 - Extended release pharmaceutical formulations with controlled impurity levels (2018-07-03),
3. 9687475 - Extended release pharmaceutical formulations with controlled impurity levels (2017-06-27),
4. 9675585 - Extended release pharmaceutical formulations (2017-06-13),
5. 4973579 - Enhancment of absorption of drugs from gastrointestinal tract using (1990-11-27),
6. 4963556 - Choline esters as absorption-enhancing agents for drug delivery through (1990-10-16),
7. 4963525 - Acylcarnitines as absorption-enhancing agents for drug delivery through (1990-10-16),
8. 4847298 - Acylcarnitines as absorption-enhancing agents for drug delivery through (1989-07-11),
9. 4835138 - Choline esters as absorption-enhancing agents for drug delivery through (1989-05-30),
10. 4822773 - Enhancement of absorption of drugs from gastrointestinal tract using (1989-04-18),
11. 4749694 - Novel lysine esters used as absorption (1988-06-07),
12. 4731360 - Acylcarnitines as absorption-enhancing agents for drug delivery through (1988-03-15),
13. 4729989 - Enhancement of absorption of drugs from gastrointestinal tract using (1988-03-08),
14. 4692441 - Chorine esters as absorption-enhancing agents for drug delivery through (1987-09-08),
15. 4537772 - Enhancing absorption of drugs from gastrointestinal tract using (1985-08-27),

Title: Joseph A. Fix: Innovator in Pharmaceutical Treatments

Introduction

Joseph A. Fix is a notable inventor based in Lawrence, Kansas, with a remarkable portfolio of 17 patents. His work primarily focuses on pharmaceutical innovations aimed at improving patient care and treatment efficacy.

Latest Patents

Among his latest patents is a method for treating diarrhea, which involves administering a low dose of 2.0-7.0 mg of cetirizine and 3.0-15.0 mg of famotidine. This innovative approach offers a new solution for patients suffering from this common ailment. Another significant patent is for extended release pharmaceutical formulations with controlled impurity levels. This invention provides a formulation of valsartan that is substantially free of valsartan R-isomer impurity, ensuring higher quality and safety for patients.

Career Highlights

Joseph has had a distinguished career, working with prominent companies such as Merck & Company, Inc. and Ezra Pharma LLC. His contributions to these organizations have been instrumental in advancing pharmaceutical research and development.

Collaborations

Throughout his career, Joseph has collaborated with talented individuals, including Jose Alexander and A. J. Repta. These partnerships have fostered innovation and enhanced the quality of his work.

Conclusion

Joseph A. Fix stands out as a significant figure in the field of pharmaceutical inventions, with a strong focus on improving treatment methods. His contributions continue to impact patient care positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…